M T Sartori Selected Research

M T Sartori Research Topics

3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 03/2001
3	Thrombosis (Thrombus) 01/2015 - 01/2000
2	Hemorrhage 01/2020 - 01/2015
2	Venous Thromboembolism 03/2001 - 01/2000
2	Thrombophilia 05/2000 - 01/2000
1	Atrial Fibrillation 01/2020
1	Afibrinogenemia (Fibrinogen Deficiency) 01/2015
1	Liver Diseases (Liver Disease) 09/2012
1	Fibrosis (Cirrhosis) 09/2012
1	Osteonecrosis (Kienbock's Disease) 07/2004
1	Hyperhomocysteinemia 07/2004
1	Osteoarthritis 07/2004
1	Abdominal Obesity 11/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2001
1	Insulin Resistance 11/2001
1	Obesity 11/2001
1	Congenital Plasminogen Deficiency 01/2000
1	hereditary Thrombophilia 01/2000
1	Disease Susceptibility (Diathesis) 01/2000
1	Activated Protein C Resistance (APC Resistance) 01/2000

3	AnticoagulantsIBA 01/2020 - 03/2001
3	Plasminogen Activator Inhibitor 1IBA 11/2001 - 05/2000
2	Prothrombin (Factor II)IBA 03/2001 - 01/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Everolimus FDA Link 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	RivaroxabanIBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2015
1	Fondaparinux (Arixtra)FDA Link 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Fibrinogen (Factor I)FDA Link 01/2015
1	Thrombin FDA Link 09/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2012
1	Plasminogen InactivatorsIBA 07/2004
1	Oral ContraceptivesIBA 03/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2001
1	Serum GlobulinsIBA 03/2001
1	Factor VIII (Coagulation Factor VIII)IBA 05/2000
1	von Willebrand FactorIBA 05/2000
1	SteroidsIBA 05/2000
1	factor V LeidenIBA 01/2000
1	Protein CIBA 01/2000
1	PlasminogenIBA 01/2000
1	AntigensIBA 01/2000

1	Therapeutics 01/2015
1	Arthroplasty 07/2004